Reaction
Superficial Injury Of Eye reporting signals
As of the last recalculation, Superficial Injury Of Eye appears in 1,057 FAERS reports alongside 20 co-occurring drug terms. The strongest observed disproportionality signal is CENEGERMIN-BKBJ (PRR 87.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Cenegermin-Bkbj | 51 | 87.2 | 87.6 |
| Carboxymethylcellulose Sodium | 33 | 71.3 | 71.6 |
| Lifitegrast | 48 | 60.6 | 60.7 |
| Dorzolamide Hydrochloride And Timolol Maleate | 21 | 53.4 | 53.5 |
| Cyclosporine | 153 | 31.5 | 31.5 |
| Prednisolone Acetate | 16 | 30.9 | 30.9 |
| Brimonidine Tartrate | 23 | 26.0 | 26.0 |
| Timolol Maleate | 12 | 24.1 | 24.1 |
| Moxifloxacin | 15 | 21.3 | 21.3 |
| Moxifloxacin Hydrochloride | 18 | 17.8 | 17.8 |
| Travoprost | 7 | 16.0 | 16.0 |
| Bimatoprost | 22 | 15.3 | 15.3 |
| Brinzolamide | 6 | 13.7 | 13.7 |
| Timolol | 8 | 13.1 | 13.1 |
| Latanoprost | 31 | 12.5 | 12.5 |
| Aflibercept | 19 | 12.2 | 12.2 |
| Ranibizumab | 11 | 8.2 | 8.2 |
| Crisaborole | 3 | 6.2 | 6.2 |
| Dupilumab | 124 | 5.6 | 5.6 |
| Adapalene | 4 | 0.4 | 0.4 |